PCP
REGN icon

Proficio Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Proficio Capital Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
+909
New +$619K 0.02% 299
2025
Q2 		– Sell
-327
Closed -$207K – 467
2025
Q1 		$207K Buy
327
+19
+6% +$13.1K 0.02% 367
2024
Q4 		$219K Buy
308
+72
+31% +$60.4K 0.02% 327
2024
Q3 		$248K Sell
236
-66
-22% -$73.4K 0.02% 243
2024
Q2 		$317K Sell
302
-2
-0.7% -$1.94K 0.03% 241
2024
Q1 		$293K Buy
304
+16
+6% +$15.2K 0.03% 251
2023
Q4 		$253K Sell
288
-66
-19% -$54.4K 0.03% 254
2023
Q3 		$291K Buy
354
+8
+2% +$6.29K 0.04% 221
2023
Q2 		$249K Sell
346
-29
-8% -$22.4K 0.03% 246
2023
Q1 		$308K Buy
+375
New +$283K 0.05% 203
2022
Q1 		– Sell
-318
Closed -$201K – 324
2021
Q4 		$201K Buy
+318
New +$196K 0.03% 296
2019
Q3 		– Sell
-274
Closed -$86K – 1205
2019
Q2 		$86K Buy
274
+30
+12% +$9.99K 0.03% 237
2019
Q1 		$100K Buy
244
+31
+15% +$12.8K 0.04% 199
2018
Q4 		$80K Buy
213
+1
+0.5% +$366 0.04% 198
2018
Q3 		$86K Buy
212
+6
+3% +$2.28K 0.03% 228
2018
Q2 		$71K Sell
206
-13
-6% -$4.07K 0.03% 268
2018
Q1 		$75K Sell
219
-37
-14% -$12.9K 0.02% 259
2017
Q4 		$96K Sell
256
-360
-58% -$146K 0.03% 212
2017
Q3 		$275K Sell
616
-34
-5% -$16.2K 0.11% 116
2017
Q2 		$310K Sell
650
-6
-0.9% -$2.63K 0.13% 110
2017
Q1 		$301K Buy
656
+393
+149% +$146K 0.13% 111
2016
Q4 		$97K Buy
263
+120
+84% +$45.6K 0.04% 186
2016
Q3 		$57K Buy
143
+24
+20% +$9.63K 0.03% 251
2016
Q2 		$49K Sell
119
-2
-2% -$770 0.03% 275
2016
Q1 		$44K Buy
121
+108
+831% +$44.5K 0.04% 231
2015
Q4 		$7K Buy
+13
New +$7.04K 0.01% 350

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Proficio Capital Partners's REGN Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 909 shares worth $567K. The stake represents 0.02% of the portfolio and ranks #299 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in REGN as recently as Q1 2025.

Proficio Capital Partners first reported a position in REGN in Q4 2015 and has held it in 26 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Proficio Capital Partners held 909 shares of Regeneron Pharmaceuticals worth $567K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Proficio Capital Partners position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Proficio Capital Partners's portfolio in Q2 2026, its #299 holding.
  • Proficio Capital Partners first reported a position in Regeneron Pharmaceuticals in Q4 2015 and has held it in 26 quarters since.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.